Both therapies prevent supine sleep position to a median of 0 % ( min-max : SPT 0.0 % to 67 % , TBT 0.0 % to 38.9 % ) , resulting in a treatment success ( AHI < 5 ) in 68.0 % of the SPT and 42.9 % of the TBT patients .